Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,574 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07553780Recruiting
Tracking Prostate Cancer Response Using PSMA Imaging Scans
This study uses a special type of imaging scan (PSMA PET) to track how well prostate cancer treatment is working by comparing scans before and after your planned therapy. The goal is to help doctors better understand which treatments work best for your type of cancer.
Lanzhou, GansuAges 18 years+ - NCT07554092Recruiting
Fast vs. Standard Casting for Baby Club Foot Treatment
This study compares two ways of treating club foot (a condition where a baby's foot is twisted inward at birth) using casts: a faster method and the traditional method. It will measure which approach works better using X-rays to see how well the foot straightens.
Peshawar, KPKAges 1 day–5 months - NCT07554495RecruitingPhase 3
Filgotinib for moderate to severe polyarticular juvenile arthritis
This trial tests filgotinib, a new medication that may help reduce joint swelling and pain in children and teens (ages 8–17) with polyarticular juvenile idiopathic arthritis—a type of childhood arthritis affecting multiple joints. You're eligible if your current arthritis medicines haven't worked well enough.
LeuvenAges 8–18 - NCT07554898RecruitingPhase 2
Low-dose Radiation Plus Orelabrutinib for Early-stage MALT Lymphoma
This trial tests combining very low-dose radiation therapy with a targeted drug called orelabrutinib (a type of cancer-fighting protein inhibitor) as a first treatment for early-stage MALT lymphoma, a slow-growing blood cancer. The goal is to see if this combination can shrink or control the cancer with fewer side effects than standard chemotherapy.
Hangzhou, ZhejiangAges 18 years+ - NCT07554911Recruiting
Improving Treatment for Severe Dry Eye Disease
This study helps doctors find better ways to treat severe dry eye disease. Researchers will perform eye exams and ask questions to understand your condition better and optimize your care.
SingaporeAges 21–99 - NCT07557810Recruiting
Thermal Ablation Plus Drugs for Overactive Thyroid
This trial tests combining heat treatment of the thyroid gland with antithyroid medications to treat primary hyperthyroidism (an overactive thyroid). It may help patients who haven't responded well to standard drugs, had side effects, or want faster symptom relief.
BeijingAges Up to 80 years - NCT07558538RecruitingEarly Phase 1
Inhaled Growth Factor Treatment for Severe Lung Failure
This early-stage trial tests whether an inhaled medication called recombinant human keratinocyte growth factor-2 (rh-KGF-2) can help patients with acute respiratory distress syndrome (ARDS)—a serious condition where the lungs cannot deliver enough oxygen to the blood. The drug is designed to help repair lung tissue damage.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07558564Recruiting
Platelet-Rich Plasma Treatment for Chronic Tendon Pain
This trial tests whether an injection of concentrated platelets from your own blood can help heal chronic tendon injuries that haven't improved with other treatments. Platelets contain natural healing factors that may reduce pain and improve function.
A CoruñaAges 18 years+ - NCT07558850Recruiting
CAR-T Cell Therapy for Treatment-Resistant Autoimmune Diseases
This study tests a new type of immune cell therapy (CAR-T cells) designed to treat severe autoimmune diseases like rheumatoid arthritis, lupus, dermatomyositis, and scleroderma that haven't responded well to standard treatments. The therapy works by modifying your own immune cells to target and eliminate the B cells that are causing your autoimmune disease.
Nanjing, JiangsuAges 18–70 - NCT07559266Recruiting
HIV Treatment and Well-Being Program for Young Gay Men
This study helps young gay and bisexual men with HIV in Vietnam improve their treatment outcomes and overall well-being. Researchers will work with you at your clinic to provide support and monitor your health while you're taking HIV medications.
Ho Chi Minh CityAges 18–24 - NCT07560696Recruiting
Web-based therapy for thinking and speech after illness
This study tests whether patients recovering from serious illness in the ICU or stroke ward can use a web-based platform called Cognishine to help rebuild their thinking skills and speech ability. The goal is to see if this online approach works well and is practical for patients receiving support from therapists.
LiverpoolAges 18 years+ - NCT07561528Recruiting
Brain Stimulation for Hard-to-Treat Obsessive-Compulsive Disorder
This study tests whether a type of brain stimulation called transcranial magnetic stimulation (TMS)—which uses magnetic pulses to activate brain cells—can help people with OCD whose symptoms haven't improved with medication. Researchers will also look at brain activity patterns to understand who benefits most.
Istanbul, BakirkoyAges 18–65 - NCT07562438RecruitingPhase 2
Lutetium-177 Treatment for Advanced Prostate Cancer
This trial tests a radioactive medication (177Lu-P17-088) designed to target and treat prostate cancer that has spread to other parts of the body and stopped responding to hormone therapy. The medication is guided to cancer cells using a special imaging scan, potentially offering a new treatment option for men who have already tried other standard therapies.
Fuzhou, FujianAges 18–90 - NCT07563244Recruiting
Computer Brain Training for Confusion in Older Adults
This study tests whether using a computer program to do brain exercises can help older adults recover from delirium—a state of confusion that sometimes happens after hospitalization. The goal is to see if this mental stimulation helps people think more clearly and recover faster.
Reus, TarragonaAges 60 years+ - NCT07565311Recruiting
Intensive Two-Week Outpatient Treatment for PTSD
This study tests a concentrated two-week outpatient program designed to help people with post-traumatic stress disorder (PTSD) recover from trauma. The goal is to see if intensive treatment delivered over a short period can effectively reduce PTSD symptoms.
OsloAges 18–65 - NCT07565519Recruiting
Exercise program for older adults receiving cancer treatment
This study tests whether a combination exercise program helps older adults who are currently undergoing cancer treatment. The program aims to improve strength, balance, and overall health during cancer therapy.
Porto Alegre, Rio Grande do SulAges 60 years+ - NCT07566507Recruiting
High-Energy Laser for Thumb Joint Arthritis
This trial tests whether a high-energy laser can reduce pain and improve function in people with arthritis at the base of the thumb (where it connects to the wrist). The laser is applied to the skin and may help by reducing inflammation and pain without surgery.
BariAges 18 years+ - NCT07566806Recruiting
Cord Plasma Eye Drops for Nerve Pain in the Eye
This trial tests whether special eye drops made from cord plasma (a blood product) can reduce chronic eye pain caused by damaged nerves in the cornea (the clear front part of your eye). You may qualify if you have had eye pain for at least 3 months without obvious surface damage.
Singapore, SingaporeAges 21 years+ - NCT07567105Recruiting
Long-term stability of open-bite orthodontic treatment
This study looks at whether orthodontic treatment for anterior open bite (a gap between upper and lower front teeth when biting down) stays stable over time. The researchers want to understand what helps the correction last.
VantaaAges Any age - NCT07567521RecruitingPhase 1/Phase 2
TRC003 for Advanced Prostate Cancer That Has Progressed
This early-stage trial tests a new drug called TRC003 for men with advanced prostate cancer that has spread and stopped responding to standard treatments. The drug is designed to target cancer cells that show a specific marker called PSMA.
Taiyuan, ShanxiAges 18 years+ - NCT07569848Recruiting
Custom ankle replacement for severe bone loss
This study tests a custom-designed ankle replacement device for people with severe ankle bone damage or loss. The device is made specifically for each patient at the Rizzoli Institute in Italy to help restore ankle function and reduce pain.
BolognaAges 35–75 - NCT07570758RecruitingPhase 2
Testing ERX1000 to Help Adults Manage Obesity
This study tests whether a new medication called ERX1000 is safe and well-tolerated in adults with obesity. The trial will help doctors understand if this treatment could be helpful for weight management.
Louisville, KentuckyAges 18–60 - NCT07570849RecruitingPhase 2
Chidamide with chemotherapy and immunotherapy for advanced bile duct cancer
This trial tests a combination of three treatments—chidamide (a new type of cancer drug), chemotherapy, and immunotherapy—for advanced intrahepatic cholangiocarcinoma (a cancer of the bile ducts inside the liver). The goal is to see if this combination can shrink tumors and help patients live longer when used as a first treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07572370Recruiting
Reducing Follow-up Visits After Breast Cancer Treatment
This study tests whether patients who have finished breast cancer treatment and are doing well can safely have fewer doctor visits and scans. Researchers want to see if reducing routine surveillance affects quality of life and health outcomes.
DublinAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,574 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.